0 Ratings

ID

42983

Description

Testosterone for Peripheral Vascular Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00504712

Link

https://clinicaltrials.gov/show/NCT00504712

Keywords

  1. 4/11/17 4/11/17 -
  2. 9/17/21 9/17/21 -
Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Hypogonadism NCT00504712

    Eligibility Hypogonadism NCT00504712

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    1. type 2 diabetes mellitus.
    Description

    Diabetes Mellitus, Non-Insulin-Dependent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0011860
    2. serum testosterone 12 nmol/l or less on two consecutive samples taken on different days and symptoms compatible with hypogonadism.
    Description

    Serum testosterone measurement Specimen Quantity | Symptoms Compatible with Hypogonadism

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0428413
    UMLS CUI [1,2]
    C0370003
    UMLS CUI [1,3]
    C1265611
    UMLS CUI [2,1]
    C1457887
    UMLS CUI [2,2]
    C1524057
    UMLS CUI [2,3]
    C0020619
    3. peripheral vascular disease as defined by
    Description

    Peripheral Vascular Disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0085096
    previous diagnosis by a specialist vascular surgeon or
    Description

    Diagnosis Vascular surgeon

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0011900
    UMLS CUI [1,2]
    C0586909
    abpi less than 0.92 and ischaemic leg pain (claudication or rest pain) or distal complications (non-healing arterial foot ulcer or gangrene).
    Description

    Ankle brachial pressure index | Pain in lower limb Ischemic | Claudication | Rest pain | Complication Distal | FOOT ULCER UNHEALED Arterial | Gangrene

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1276055
    UMLS CUI [2,1]
    C0023222
    UMLS CUI [2,2]
    C0475224
    UMLS CUI [3]
    C1456822
    UMLS CUI [4]
    C0234253
    UMLS CUI [5,1]
    C0009566
    UMLS CUI [5,2]
    C0205108
    UMLS CUI [6,1]
    C0744185
    UMLS CUI [6,2]
    C0221464
    UMLS CUI [7]
    C0017086
    4. agreement to maintain antihypertensive and antilipid treatments at prior doses during 3 month duration of study.
    Description

    Antihypertensive therapy Dosage Maintenance | Antilipidemic Agent Dosage Maintenance

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0585941
    UMLS CUI [1,2]
    C0178602
    UMLS CUI [1,3]
    C0024501
    UMLS CUI [2,1]
    C1516000
    UMLS CUI [2,2]
    C0178602
    UMLS CUI [2,3]
    C0024501
    5. ability to give written informed consent after verbal and written explanation in the english language.
    Description

    Informed Consent Explanation English Language

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0021430
    UMLS CUI [1,2]
    C0681841
    UMLS CUI [1,3]
    C0376245
    6. ability to comply with all study requirements.
    Description

    Protocol Compliance

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0525058
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    1. current or previous breast cancer.
    Description

    Breast Carcinoma

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0678222
    2. current or previous prostate cancer.
    Description

    Prostate carcinoma

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0600139
    3. raised prostate specific antigen (psa) or abnormal per rectal examination unless prostate cancer excluded after specialist urology opinion.
    Description

    Raised prostate specific antigen | Prostate specific antigen abnormal Rectal examination | Prostate carcinoma Excluded

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0178415
    UMLS CUI [2,1]
    C0580555
    UMLS CUI [2,2]
    C0199900
    UMLS CUI [3,1]
    C0600139
    UMLS CUI [3,2]
    C2828389
    4. severe symptoms of benign prostatic hypertrophy (‘prostatism’)
    Description

    Benign prostatic hypertrophy Severe symptoms | Prostatism

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1704272
    UMLS CUI [1,2]
    C0436345
    UMLS CUI [2]
    C0242453
    5. treatment with testosterone in the 3 months prior to the trial.
    Description

    Testosterone

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0039601
    6. investigational drug treatment in the 3 months prior to the trial.
    Description

    Investigational New Drug

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0013230

    Similar models

    Eligibility Hypogonadism NCT00504712

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Diabetes Mellitus, Non-Insulin-Dependent
    Item
    1. type 2 diabetes mellitus.
    boolean
    C0011860 (UMLS CUI [1])
    Serum testosterone measurement Specimen Quantity | Symptoms Compatible with Hypogonadism
    Item
    2. serum testosterone 12 nmol/l or less on two consecutive samples taken on different days and symptoms compatible with hypogonadism.
    boolean
    C0428413 (UMLS CUI [1,1])
    C0370003 (UMLS CUI [1,2])
    C1265611 (UMLS CUI [1,3])
    C1457887 (UMLS CUI [2,1])
    C1524057 (UMLS CUI [2,2])
    C0020619 (UMLS CUI [2,3])
    Peripheral Vascular Disease
    Item
    3. peripheral vascular disease as defined by
    boolean
    C0085096 (UMLS CUI [1])
    Diagnosis Vascular surgeon
    Item
    previous diagnosis by a specialist vascular surgeon or
    boolean
    C0011900 (UMLS CUI [1,1])
    C0586909 (UMLS CUI [1,2])
    Ankle brachial pressure index | Pain in lower limb Ischemic | Claudication | Rest pain | Complication Distal | FOOT ULCER UNHEALED Arterial | Gangrene
    Item
    abpi less than 0.92 and ischaemic leg pain (claudication or rest pain) or distal complications (non-healing arterial foot ulcer or gangrene).
    boolean
    C1276055 (UMLS CUI [1])
    C0023222 (UMLS CUI [2,1])
    C0475224 (UMLS CUI [2,2])
    C1456822 (UMLS CUI [3])
    C0234253 (UMLS CUI [4])
    C0009566 (UMLS CUI [5,1])
    C0205108 (UMLS CUI [5,2])
    C0744185 (UMLS CUI [6,1])
    C0221464 (UMLS CUI [6,2])
    C0017086 (UMLS CUI [7])
    Antihypertensive therapy Dosage Maintenance | Antilipidemic Agent Dosage Maintenance
    Item
    4. agreement to maintain antihypertensive and antilipid treatments at prior doses during 3 month duration of study.
    boolean
    C0585941 (UMLS CUI [1,1])
    C0178602 (UMLS CUI [1,2])
    C0024501 (UMLS CUI [1,3])
    C1516000 (UMLS CUI [2,1])
    C0178602 (UMLS CUI [2,2])
    C0024501 (UMLS CUI [2,3])
    Informed Consent Explanation English Language
    Item
    5. ability to give written informed consent after verbal and written explanation in the english language.
    boolean
    C0021430 (UMLS CUI [1,1])
    C0681841 (UMLS CUI [1,2])
    C0376245 (UMLS CUI [1,3])
    Protocol Compliance
    Item
    6. ability to comply with all study requirements.
    boolean
    C0525058 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Breast Carcinoma
    Item
    1. current or previous breast cancer.
    boolean
    C0678222 (UMLS CUI [1])
    Prostate carcinoma
    Item
    2. current or previous prostate cancer.
    boolean
    C0600139 (UMLS CUI [1])
    Raised prostate specific antigen | Prostate specific antigen abnormal Rectal examination | Prostate carcinoma Excluded
    Item
    3. raised prostate specific antigen (psa) or abnormal per rectal examination unless prostate cancer excluded after specialist urology opinion.
    boolean
    C0178415 (UMLS CUI [1])
    C0580555 (UMLS CUI [2,1])
    C0199900 (UMLS CUI [2,2])
    C0600139 (UMLS CUI [3,1])
    C2828389 (UMLS CUI [3,2])
    Benign prostatic hypertrophy Severe symptoms | Prostatism
    Item
    4. severe symptoms of benign prostatic hypertrophy (‘prostatism’)
    boolean
    C1704272 (UMLS CUI [1,1])
    C0436345 (UMLS CUI [1,2])
    C0242453 (UMLS CUI [2])
    Testosterone
    Item
    5. treatment with testosterone in the 3 months prior to the trial.
    boolean
    C0039601 (UMLS CUI [1])
    Investigational New Drug
    Item
    6. investigational drug treatment in the 3 months prior to the trial.
    boolean
    C0013230 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial